Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Schouw & Co. share buy-back programme, week 43 2025
-
Evaxion appoints Dr Helen Tayton-Martin as new Chief Executive Officer
-
Signify share repurchase period update
-
OXB to participate in upcoming investor conferences and events
-
Rectitude Holdings Partners with Pansik Technology Pte Ltd. to Drive Expansion in Renewable Energy Solutions
-
Rectitude Holdings Partners with Pansik Technology Pte Ltd. to Drive Expansion in Renewable Energy Solutions
-
KFSHRC Launches the First Facility for Gene and Cell Therapy Manufacturing in Saudi Arabia
-
Abstract’s Founder to Discuss How Real-World Experience Is Shaping the Path to AGI at Future Lawyer USA 2025
-
Sydbank A/S share buyback programme: transactions in week 43
-
BioNTech to Report Third Quarter 2025 Financial Results and Corporate Update on November 3, 2025
-
BexBack Launches Crypto Futures Trading with Up to 100x Leverage, No KYC Access and $100 Welcome Bonus
-
Form 8.3 - Avadel Pharmaceuticals plc
-
LIFE AI Joins First Ever FastTrack AI Accelerator Powered By GenAI Fund and NVIDIA Inception Program
-
Abaxx Exchange Integrates with TradingView, Extending LNG and Singapore Gold Futures Contract Liquidity to 100M+ Users
-
Blaqclouds Executes Blockchain Partnership with Super Studios USA, Led by Former Ridley Scott & Associates Executive Producer Developing a Billion-Dollar Entertainment Complex in Texas
-
Intellia Therapeutics Provides Update on MAGNITUDE Clinical Trials of Nexiguran Ziclumeran (nex-z)
-
BrainsWay Announces Additional Minority-Stake Investments in Leading U.S. Mental Health Providers
-
BioRestorative Awarded Notice of Allowance for Japanese Patent – Expands Protection for Potential Cell-Based Alternative to Multi-Billion Dollar GLP-1 Drug Market
-
MicrobiotiX Receives IND Approval for Novel Bacteriophage Drug MP101
-
Zevra Therapeutics Announces Details for Q3 2025 Financial Results Call
-
Telesat schedules third quarter 2025 earnings conference call for November 4, 2025
-
On the Resolutions Adopted at the Extraordinary General Meeting of Shareholders
-
Ottco and Royal Vopak sign strategic agreement to establish a joint venture in the special economic zone at Duqm
-
Alpha Modus Holdings, Inc. (NASDAQ: AMOD) To Launch AlphaCash, Appoints Puneet “Pete” Vij as VP of Technology to Lead Nationwide Rollout
-
Sound Group Collaborates With HKUST(GZ) To Cultivate AI Innovation Talent
-
A.P. Møller - Mærsk A/S – Transactions in connection with share buy-back program
-
Zenas BioPharma Announces Positive Results from Phase 2 MoonStone Trial of Obexelimab in Relapsing Multiple Sclerosis
-
Kraig Biocraft Laboratories Promotes Dr. Xiaoli Zhang to Chief Scientist Following Series of Groundbreaking Scientific Breakthroughs
-
Arcadia Celebrates Customer Success, Innovation, and New AI-Driven Solutions at Aggregate 2025
-
Petal Health and Shoppers Drug Mart Collaborate to Expand Access to Care Across Canada
-
Heineken Holding N.V. reports transactions under its current share buyback programme
-
First Northwest Bancorp Announces Third Quarter 2025 Results
-
Neumora Therapeutics Announces Initiation of Phase 1 Clinical Study of M4 Positive Allosteric Modulator NMRA-898
-
Currency Exchange International Announces Adoption of Shareholder Rights Plan
-
Tonix Pharmaceuticals Presented Data on Tonmya™ (Cyclobenzaprine HCl Sublingual Tablets) at the 2025 American College of Rheumatology (ACR) Convergence
-
TECHNATION announces Kevin d’Entremont as President and CEO
-
Nurix Therapeutics Announces Closing of $250.0 Million Registered Offering of Common Stock
-
Lakeland Financial Reports Third Quarter Performance; Net Income Grows by 13% to $26.4 Million, as Net Interest Income Expands by 14%
-
Harrow To Report Third Quarter 2025 Financial Results After Market Close on November 10, 2025
-
JPMorgan Announces Cash Distributions for the JPMorgan ETFs
-
Kymera Therapeutics Presents New Preclinical Data for KT-579, a First-in-Class, Oral IRF5 Degrader, at the American College of Rheumatology Annual Meeting
-
Autolus Therapeutics Presents Clinical Data Updates at the American College of Rheumatology Convergence 2025
-
Chijet Motor Company Announces Closing of $300 Million Private Placement in Cryptocurrency
-
Cabaletta Bio Presents Positive Clinical Data and Development Updates for Rese-cel at ACR Convergence 2025
-
Electra Advances Idaho Cobalt-Copper Assets as Cornerstone of America’s Critical Minerals Independence
-
BridgeBio Reports Positive Phase 3 Results for Small Molecule BBP-418 in LGMD2I/R9 FORTIFY Study
-
Carbon Streaming Announces Appointment of Jonathan Rubenstein as Expert Consultant
-
Nutriband Co-Founder Gareth Sheridan Returns as CEO
-
interface.ai Expands Leadership Team with Steve Swanston as CRO to Advance its Mission of Transforming Banking Through Agentic AI
-
SD Government, a Gogo Company, receives federal contract to supply airborne communications for US agency
